effects of Parkinson's disease. Since the trial was halted last summer, many of these people, supported by organizations and thousands of well-wishers from around the Parkinson's community, have pleaded with Amgen to reinstate those subjects who wish to continue with the treatment and are willing to be carefully followed to generate ongoing data. We understand and fully accept that such reinstatement of treatment should take place only with appropriate waivers that would hold the company harmless in event of any complications, whether foreseen or unforeseen, and with the approval of the relevant Institutional Review Boards."
"The safety issues of neutralizing antibodies (found in some of the human subjects) and of cerebellar degeneration involving high-dosage GDNF (in some non-human primate subjects) need to be investigated and understood. If subjects are willing to offer themselves for continuing GDNF infusion with all of these safety concerns fully explained and understood by the subjects, then the Parkinson community science as well as patients can gain much new information related to the safety of GDNF infusions."
"In summary, the decision is a mistake because it denies the patients and their doctors the opportunity to continue with a potentially useful, albeit yet unproven, treatment, and it denies us all the opportunity to gather more scientific data about the long-term effects of GDNF. We hope very much that this company, which has long held a position of high respect in the business and health communities, will consider reversing its decision, and soon. In the meantime, the coalition of patient-voluntary groups which besides PDF includes the Parkinson's Action Network and the Parkinson's Pipeline Project -- will continue fighting for patients' interests as long as it takes."
Page: 1 2 Related biology news :1
Contact: Christiana Evers
Parkinson's Disease Foundation
. A nurse makes the decision on who will live2
. Cells use noise to make cell-fate decisions3
. Group decisions: From compromise to leadership in pigeon homing4
. AIUM supports FDA decision to deny over-the-counter use of handheld doppler fetoscopes5
. Titans of biodiversity science call for united, authoritative voice to inform decision-makers6
. Dover intelligent design decision to be topic of national forum7
. Honeybee decision-making ability rivals any department committee8
. Even at small scales, the big decisions are made at the water cooler9
. Amid growing public concerns, bioscience firms begin formalizing ethical decision-making practices10
. Ethical decision-making at bioscience companies11
. Dover decision is good for long-term economic and scientific strength